The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. (Q45405807)
Jump to navigation
Jump to search
scientific article published in March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. |
scientific article published in March 2007 |
Statements
1 reference
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. (English)
1 reference
1 reference
Ronald Mitsuyasu
1 reference
Rebecca Gelman
1 reference
Deborah Weng Cherng
1 reference
Alan Landay
1 reference
John Fahey
1 reference
Richard Reichman
1 reference
Alejo Erice
1 reference
R Pat Bucy
1 reference
J Michael Kilby
1 reference
Michael M Lederman
1 reference
Carol D Hamilton
1 reference
Juan Lertora
1 reference
Becky L White
1 reference
Anne-Marie Duliege
1 reference
Richard B Pollard
1 reference
AIDS Clinical Trials Group 328 Study Team
1 reference
1 March 2007
1 reference
1 reference
Identifiers
1 reference